UNLABELLED: The biological function of the SART-1 gene product is demonstrated and its potential as a target for cancer gene therapy is discussed. MATERIALS AND METHODS: The SART-1 gene was transduced by a recombinant adenovirus vector and its expression was promoted by a CMV promoter. RESULTS: The transduction efficiency by recombinant adenoviruses in A549 and MCF-7 cells was determined using a vector expressing luciferase, which showed high expression in the cells. Cell count analysis using Trypan-Blue dye exclusion showed that SART-1 gene transduction inhibited cell growth. Flow cytometry analysis suggested that SART-1 gene transduction induced cell cycle arrest followed by apoptosis. Western blot analysis confirmed that the apoptosis pathway was activated by SART-1 gene transduction. CONCLUSION: These results show that SART-1 gene transduction induces cell cycle arrest leading to apoptosis and suggest the possibility of gene therapy against cancer. In addition, SART-1 is known to be a tumor antigen in a range of cancers recognized by T cells, thus a potential strategy would be the combination of suicide gene therapy with immuno-gene therapy.
UNLABELLED: The biological function of the SART-1 gene product is demonstrated and its potential as a target for cancer gene therapy is discussed. MATERIALS AND METHODS: The SART-1 gene was transduced by a recombinant adenovirus vector and its expression was promoted by a CMV promoter. RESULTS: The transduction efficiency by recombinant adenoviruses in A549 and MCF-7 cells was determined using a vector expressing luciferase, which showed high expression in the cells. Cell count analysis using Trypan-Blue dye exclusion showed that SART-1 gene transduction inhibited cell growth. Flow cytometry analysis suggested that SART-1 gene transduction induced cell cycle arrest followed by apoptosis. Western blot analysis confirmed that the apoptosis pathway was activated by SART-1 gene transduction. CONCLUSION: These results show that SART-1 gene transduction induces cell cycle arrest leading to apoptosis and suggest the possibility of gene therapy against cancer. In addition, SART-1 is known to be a tumor antigen in a range of cancers recognized by T cells, thus a potential strategy would be the combination of suicide gene therapy with immuno-gene therapy.
Authors: Cloe de Luxán-Hernández; Julia Lohmann; Eduardo Tranque; Jana Chumova; Pavla Binarova; Julio Salinas; Magdalena Weingartner Journal: Life Sci Alliance Date: 2022-10-20
Authors: J E Olson; X Wang; E L Goode; V S Pankratz; Z S Fredericksen; R A Vierkant; P D P Pharoah; J R Cerhan; F J Couch Journal: Breast Cancer Res Treat Date: 2009-04-18 Impact factor: 4.872
Authors: Andreas Keller; Christian Harz; Mark Matzas; Benjamin Meder; Hugo A Katus; Nicole Ludwig; Ulrike Fischer; Eckart Meese Journal: PLoS One Date: 2011-06-10 Impact factor: 3.240
Authors: Sander Bekeschus; Kristian Wende; Mohamed Mokhtar Hefny; Katrin Rödder; Helena Jablonowski; Anke Schmidt; Thomas von Woedtke; Klaus-Dieter Weltmann; Jan Benedikt Journal: Sci Rep Date: 2017-06-05 Impact factor: 4.379